PACIRA BIOSCIENCES ($PCRX) posted quarterly earnings results on Thursday, May 8th. The company reported earnings of $0.62 per share, beating estimates of $0.61 by $0.01. The company also reported revenue of $168,920,000, missing estimates of $179,545,795 by $-10,625,795.
You can see Quiver Quantitative's $PCRX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
PACIRA BIOSCIENCES Insider Trading Activity
PACIRA BIOSCIENCES insiders have traded $PCRX stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $PCRX stock by insiders over the last 6 months:
- JONATHAN SLONIN (Chief Medical Officer) sold 879 shares for an estimated $16,173
- DARYL GAUGLER (Chief Operating Officer) sold 500 shares for an estimated $9,880
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PACIRA BIOSCIENCES Hedge Fund Activity
We have seen 109 institutional investors add shares of PACIRA BIOSCIENCES stock to their portfolio, and 126 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PACER ADVISORS, INC. removed 2,661,169 shares (-81.6%) from their portfolio in Q1 2025, for an estimated $66,130,049
- UBS GROUP AG added 1,184,034 shares (+620.7%) to their portfolio in Q4 2024, for an estimated $22,307,200
- POINT72 ASSET MANAGEMENT, L.P. added 1,075,673 shares (+inf%) to their portfolio in Q4 2024, for an estimated $20,265,679
- MILLENNIUM MANAGEMENT LLC added 879,473 shares (+145.1%) to their portfolio in Q4 2024, for an estimated $16,569,271
- INVESCO LTD. removed 683,699 shares (-74.0%) from their portfolio in Q4 2024, for an estimated $12,880,889
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 505,307 shares (-43.8%) from their portfolio in Q4 2024, for an estimated $9,519,983
- MORGAN STANLEY removed 491,115 shares (-30.8%) from their portfolio in Q4 2024, for an estimated $9,252,606
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
